Cochrane Abstracts
Intravesical gemcitabine for non‐muscle invasive bladder cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravesical Gemcitabine for Non‐muscle Invasive Bladder Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437239/2/Intravesical_gemcitabine_for_non.
Intravesical gemcitabine for non‐muscle invasive bladder cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437239/2/Intravesical_gemcitabine_for_non. Accessed April 9, 2026.
Intravesical gemcitabine for non‐muscle invasive bladder cancer. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437239/2/Intravesical_gemcitabine_for_non
Intravesical Gemcitabine for Non‐muscle Invasive Bladder Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 April 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437239/2/Intravesical_gemcitabine_for_non.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravesical gemcitabine for non‐muscle invasive bladder cancer
ID - 437239
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437239/2/Intravesical_gemcitabine_for_non
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
